| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.4 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |